Vitronectin, a Novel Urinary Proteomic Biomarker, Promotes Cell Pyroptosis in Juvenile Systemic Lupus Erythematosus

Table 1

Demography of clinical characteristics for JSLE patients and healthy controls ().

Parameters	Healthy controls ()	Inactive JSLE ()	Active JSLE ()
Age
Gender (M/F)	2/7	0/9	0/10
Disease duration (year)	NA.
SLEDAI	NA.		^#
SLICC	NA.
Hematuria	0/9	1/9	5/10
Proteinuria	0/9	1/9	4/10
C3 (g/L)	NA.		^#
C4 (g/L)	NA.		^##
ANA (g/L)	NA.		^###
dsDNA (g/L)	NA.		^##
ESR (mm/h)	NA.		^#
Creatinine (μmol/L)
Uric acid (μmol/L)
AST/ALT ratio
CRP (mg/L)
WBC (10^9/L)
HB (g/L)
PLT (g/L)

The statistically significant differences were shown between JSLE patients and healthy controls (, ), as well as the significant differences between the active and inactive JSLE patients (^#, ^##, and ^###). There are no statistically significant differences in the parameters of gender, disease duration, SLICC, proteinuria, uric acid, CRP, WBC, and PLT among groups.